399 related articles for article (PubMed ID: 23630050)
1. Systematic review of upper-limb function measurement methods in botulinum toxin intervention for focal spasticity.
Ashford S; Turner-Stokes L
Physiother Res Int; 2013 Sep; 18(3):178-89. PubMed ID: 23630050
[TBL] [Abstract][Full Text] [Related]
2. Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity.
Demetrios M; Khan F; Turner-Stokes L; Brand C; McSweeney S
Cochrane Database Syst Rev; 2013 Jun; (6):CD009689. PubMed ID: 23740539
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin to treat upper-limb spasticity in hemiparetic patients: analysis of function and kinematics of reaching movements.
Bensmail D; Robertson JV; Fermanian C; Roby-Brami A
Neurorehabil Neural Repair; 2010; 24(3):273-81. PubMed ID: 20067949
[TBL] [Abstract][Full Text] [Related]
4. Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial: effect on impairment, activity limitation, and pain.
Shaw LC; Price CI; van Wijck FM; Shackley P; Steen N; Barnes MP; Ford GA; Graham LA; Rodgers H;
Stroke; 2011 May; 42(5):1371-9. PubMed ID: 21415398
[TBL] [Abstract][Full Text] [Related]
5. Botulinum neurotoxins for post-stroke spasticity in adults: a systematic review.
Elia AE; Filippini G; Calandrella D; Albanese A
Mov Disord; 2009 Apr; 24(6):801-12. PubMed ID: 19224614
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Botulinum Toxin Treatment for Upper Limb Spasticity Poststroke Over Different ICF Domains: A Systematic Review and Meta-Analysis.
Andringa A; van de Port I; van Wegen E; Ket J; Meskers C; Kwakkel G
Arch Phys Med Rehabil; 2019 Sep; 100(9):1703-1725. PubMed ID: 30796921
[TBL] [Abstract][Full Text] [Related]
7. Initial psychometric evaluation of the Arm Activity Measure (ArmA): a measure of activity in the hemiparetic arm.
Ashford S; Turner-Stokes L; Siegert R; Slade M
Clin Rehabil; 2013 Aug; 27(8):728-40. PubMed ID: 23426566
[TBL] [Abstract][Full Text] [Related]
8. Contemporary pharmacologic treatments for spasticity of the upper limb after stroke: a systematic review.
Olvey EL; Armstrong EP; Grizzle AJ
Clin Ther; 2010 Dec; 32(14):2282-303. PubMed ID: 21353101
[TBL] [Abstract][Full Text] [Related]
9. Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial.
Turner-Stokes L; Baguley IJ; De Graaff S; Katrak P; Davies L; McCrory P; Hughes A
J Rehabil Med; 2010 Jan; 42(1):81-9. PubMed ID: 20111849
[TBL] [Abstract][Full Text] [Related]
10. Frequency and characteristics of goal attainment following BoNT-A injection for management of spasticity.
Mullins D; Winter A; Fini N; Dixon C; Aldous S; Palit M; Holland AE
Disabil Rehabil; 2016 Sep; 38(19):1927-33. PubMed ID: 26714558
[TBL] [Abstract][Full Text] [Related]
11. Does botulinum toxin treatment improve upper limb active function?
Levy J; Molteni F; Cannaviello G; Lansaman T; Roche N; Bensmail D
Ann Phys Rehabil Med; 2019 Jul; 62(4):234-240. PubMed ID: 29960017
[TBL] [Abstract][Full Text] [Related]
12. Goal setting, using goal attainment scaling, as a method to identify patient selected items for measuring arm function.
Ashford S; Jackson D; Turner-Stokes L
Physiotherapy; 2015 Mar; 101(1):88-94. PubMed ID: 24954806
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
Buyukavci R; Akturk S; Ersoy Y
Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
[TBL] [Abstract][Full Text] [Related]
14. Use of botulinum toxin type A and type B for spasticity in upper and lower limbs.
Bell KR; Williams F
Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):821-35. PubMed ID: 14580040
[TBL] [Abstract][Full Text] [Related]
15. Common goal areas in the treatment of upper limb spasticity: a multicentre analysis.
Ashford S; Fheodoroff K; Jacinto J; Turner-Stokes L
Clin Rehabil; 2016 Jun; 30(6):617-22. PubMed ID: 26141809
[TBL] [Abstract][Full Text] [Related]
16. Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: a preliminary analysis of goals and outcomes.
Ashford S; Turner-Stokes L
Disabil Rehabil; 2009; 31(3):220-6. PubMed ID: 18608366
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin A: Findings from the prospective, observational Upper Limb International Spasticity (ULIS-III) cohort study.
Turner-Stokes L; Jacinto J; Fheodoroff K; Brashear A; Maisonobe P; Lysandropoulos A; Ashford S;
J Rehabil Med; 2021 Feb; 53(2):jrm00157. PubMed ID: 33616192
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of botulinum toxin type A for upper limb spasticity after stroke or traumatic brain injury: a systematic review with meta-analysis and trial sequential analysis.
Dong Y; Wu T; Hu X; Wang T
Eur J Phys Rehabil Med; 2017 Apr; 53(2):256-267. PubMed ID: 27834471
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin in poststroke spasticity.
Ozcakir S; Sivrioglu K
Clin Med Res; 2007 Jun; 5(2):132-8. PubMed ID: 17607049
[TBL] [Abstract][Full Text] [Related]
20. Use of botulinum toxin in stroke patients with severe upper limb spasticity.
Bhakta BB; Cozens JA; Bamford JM; Chamberlain MA
J Neurol Neurosurg Psychiatry; 1996 Jul; 61(1):30-5. PubMed ID: 8676154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
